A two-part single and multiple dose study to assess the safety , pharmacokinetics and effects of AZD3293 in healthy Japanese young and elderly volunteers

Study identifier:D5010C00003

ClinicalTrials.gov identifier:NCT02005211

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Effect on Biomarkers of AZD3293 in Healthy Japanese Male and Non-Fertile Female Volunteers including Elderly

Medical condition

Healthy Japanese young and elderly male and non-fertile female volunteers

Phase

Phase 1

Healthy volunteers

Yes

Study drug

AZD3293, Placebo

Sex

All

Actual Enrollment

114

Study type

Interventional

Age

20 Years - 80 Years

Date

Study Start Date: 01 Dec 2013
Primary Completion Date: 01 Jul 2014
Study Completion Date: 01 Jul 2014

Study design

Allocation: Randomized
Endpoint Classification: Safety Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Basic Science

Verification:

Verified 01 Sept 2016 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria